<- Go Home
DexCom, Inc.
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally.
Market Cap
$27.0B
Volume
3.6M
Cash and Equivalents
$939.2M
EBITDA
$886.8M
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
$2.5B
Profit Margin
62.73%
52 Week High
$142.00
52 Week Low
$62.34
Dividend
N/A
Price / Book Value
11.08
Price / Earnings
41.64
Price / Tangible Book Value
11.74
Enterprise Value
$26.4B
Enterprise Value / EBITDA
28.73
Operating Income
$681.5M
Return on Equity
29.41%
Return on Assets
6.25
Cash and Short Term Investments
$3.1B
Debt
$2.6B
Equity
$2.4B
Revenue
$3.9B
Unlevered FCF
$646.9M
Sector
Health Care Equipment and Supplies
Category
N/A